Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU pre-registration deadline for phase-in chemicals nears

This article was originally published in RAJ Devices

Executive Summary

Companies subject to the REACH chemicals legislation in the European Union – including medtech manufacturers – have until 30 November to pre-register certain “phase-in” chemical substances with the European Chemicals Agency (ECHA)1. The same registration deadline applies to high-volume manufacturers and importers. The ECHA has published this reminder, as well as a number of other announcements, in the past month.

You may also be interested in...



Stakeholders Deliberate on Developing US Social Media Guidance

Jeanette Marchant reports on discussions at the US Food and Drug Administration public hearing on how drug and medical device companies should use the internet and social media to promote regulated products.

Stakeholders Deliberate on Developing US Social Media Guidance

Jeanette Marchant reports on discussions at the US Food and Drug Administration public hearing on how drug and medical device companies should use the internet and social media to promote regulated products.

Asian group identifies criteria for device nomenclature system

The Asian Harmonization Working Party agreed six criteria for a medical device nomenclature system at its 14th meeting in Hong Kong on 4-7 November 20091. The requirements ? which will help in the selection of a nomenclature system service provider ? cover charges for using the system; its governance; ownership of the database; response times to requests; the system’s future development; and further use.

UsernamePublicRestriction

Register

SC095767

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel